Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician

Andrew S Tseng; Gurukripa N Kowlgi; Christopher V DeSimone

doi:10.1016/j.mayocp.2021.01.010

Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician

Mayo Clin Proc. 2021 Aug;96(8):2230-2242. doi: 10.1016/j.mayocp.2021.01.010. Epub 2021 Jun 10.

Authors

Andrew S Tseng¹, Gurukripa N Kowlgi¹, Christopher V DeSimone²

Affiliations

¹ Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN.
² Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN. Electronic address: desimone.christopher@mayo.edu.

PMID: 34119307
DOI: 10.1016/j.mayocp.2021.01.010

Abstract

The management of atrial fibrillation (AF) in the outpatient setting has become more complex with the utilization of antiarrhythmic drugs (AADs) and increasing complexity of comorbid conditions. The primary care clinician is critically involved in the pharmacologic management of AF, whether it be direct prescription of AADs or managing potential drug-drug interactions with other medications. In this review, we provide instructive, high-yield clinical scenarios and quick clinical references to increase familiarity and comfort with the use of AADs.

Publication types

Review

MeSH terms

Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / drug therapy*
Humans
Outpatients*
Primary Health Care / methods*
Recurrence

Substances

Anti-Arrhythmia Agents